BridgeBio Pharma Income Statement (2019-2025) | BBIO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -1.67M-1.94M26.70M13.82M-4.01M-10.75M8.13M0.12M0.46M8.50M2.34M-0.83M1.69M73.75M0.34M1.87M1.83M1.64M4.09M1.75M211.12M2.17M2.73M5.88M116.63M110.56M120.70M
Cost of Revenue 1.45M1.55M1.35M0.74M0.65M0.65M0.60M0.60M0.60M0.60M0.60M0.60M2.08M2.64M3.65M6.56M
Gross Profit 0.89M-2.38M72.40M-0.40M1.22M1.18M1.04M3.49M1.15M210.52M1.57M2.13M3.80M113.99M106.91M114.14M
Operating items
Research & Development 44.85M52.33M55.28M57.48M68.22M86.60M92.05M90.17M122.56M101.96M104.31M122.20M107.65M108.40M92.51M90.90M92.86M107.49M125.14M130.23M140.97M114.69M120.44M130.35M111.43M111.23M112.87M
Selling, General & Administrative 18.90M16.99M23.50M34.97M34.26M37.97M36.02M37.44M45.41M45.97M46.08M54.75M43.71M36.43M31.19M31.86M31.11M36.12M35.78M47.58M65.81M59.52M68.82M94.78M106.36M129.15M137.62M
Restructuring Costs 22.66M8.40M5.02M7.69M3.37M3.53M0.27M0.75M3.40M2.89M4.62M4.69M0.57M0.81M8.84M
Other Operating Expenses 2.50M0.11M1.45M1.55M1.35M0.70M0.74M0.65M0.65M0.60M0.60M0.60M0.60M0.60M0.60M2.08M2.64M3.65M6.56M
Operating Expenses 63.75M69.32M81.27M92.46M102.49M124.57M128.07M127.61M167.97M148.04M151.84M178.50M175.37M153.92M129.45M131.10M127.99M147.74M161.78M179.16M210.78M177.71M194.48M231.91M221.00M244.84M265.90M
Operating Income -63.75M-69.32M-54.53M-78.64M-102.49M-124.57M-119.94M-127.49M-167.50M-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M
EBIT -63.75M-69.32M-54.53M-78.64M-102.49M-124.57M-119.94M-127.49M-167.50M-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M
Non-operating items
Interest & Investment Income 2.11M1.66M2.74M2.41M1.94M0.93M0.69M0.45M0.39M0.32M0.23M0.18M0.27M0.77M2.42M4.09M4.15M4.51M3.79M5.58M4.08M5.20M3.30M4.68M5.38M3.90M6.24M
Other Non Operating Income -1.52M0.22M-0.17M-0.16M0.47M-1.83M0.01M2.98M5.77M2.46M-0.68M28.28M-7.58M-10.82M6.33M4.56M-0.60M1.48M-5.28M21.78M-26.59M-0.63M1.80M-21.16M6.55M16.46M
Non Operating Income -5.68M-5.02M-6.13M-5.51M-1.59M-11.65M-10.23M-7.54M5.77M-8.06M-11.52M58.98M-27.65M77.62M-11.08M-11.34M-16.57M-14.60M-21.80M7.09M-36.50M100.00M27.50M-40.21M-65.24M-47.38M-41.28M
Net income details
EBT -63.32M-69.60M-53.91M-79.27M-104.56M-134.39M-130.18M-138.00M-176.85M-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-36.16M-164.25M-266.24M-141.13M-169.61M-186.48M
Tax Provisions 1.15M-1.54M
Profit After Tax -69.44M-0.07M-60.66M-84.15M-104.08M-136.21M-130.17M-135.03M-171.08M-102.07M-161.02M-152.28M-201.33M-2.56M-140.19M-140.57M-142.73M-160.70M-179.49M-170.33M-36.16M-75.54M-164.25M-267.39M-169.61M-183.76M-184.94M
Equity Income -4.60M-4.96M-6.59M-4.72M-7.92M-6.56M-16.70M-15.56M-20.19M-15.83M
Income from Non-Controlling Interests -8.25M-8.37M-0.68M-10.69M-12.23M-15.18M-14.31M-15.04M-8.00M-5.73M-5.08M-5.11M-4.93M7.30M-2.85M-2.98M-2.58M-2.80M-2.49M-2.18M-0.94M-2.09M-2.21M-2.34M-2.19M-1.85M-2.19M
Income from Continuing Operations -63.32M-69.60M-53.91M-79.27M-104.56M-134.39M-130.18M-138.00M-176.85M-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-36.16M-164.25M-267.39M-141.13M-169.61M-184.94M
Consolidated Net Income -63.32M-69.60M-53.91M-79.27M-104.56M-134.39M-130.18M-138.00M-176.85M-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-36.16M-164.25M-267.39M-141.13M-169.61M-184.94M
Income towards Parent Company -63.32M-69.60M-53.91M-79.27M-104.56M-134.39M-130.18M-138.00M-176.85M-104.53M-160.33M-180.57M-193.75M-99.69M-146.52M-145.13M-142.13M-162.18M-174.21M-192.11M-19.05M-36.16M-164.25M-267.39M-141.13M-169.61M-184.94M
Net Income towards Common Stockholders -61.19M-65.96M-59.98M-73.46M-91.85M-121.03M-115.86M-119.98M-163.08M-96.35M-155.94M-147.18M-196.40M-9.86M-137.34M-137.59M-140.16M-157.90M-177.00M-168.15M-35.22M-73.46M-162.04M-265.05M-167.42M-181.90M-182.74M
Additional items
EPS (Basic) -0.66-0.71-0.51-0.62-0.78-1.03-0.98-1.01-1.18-0.66-1.06-1.02-1.35-0.07-0.93-0.92-0.92-0.98-1.08-0.96-0.20-0.39-0.86-1.42-0.88-0.95-0.95
EPS (Weighted Average and Diluted) -1.02-1.16-1.06-1.02-1.35-0.07-0.93-0.92-0.92-0.98-1.08-0.96-0.20-0.39-0.86-1.42-0.88-0.95-0.95
Shares Outstanding (Weighted Average) 115.00M115.00M116.76M123.77M123.77M121.37M122.36M122.57M148.96M149.28M149.77M147.17M147.61M148.25M148.25M149.48M151.37M160.50M162.47M173.97M175.83M187.13M188.03M188.99M190.19M189.88M191.17M
Shares Outstanding (Diluted Average) 118.00M146.75M146.66M144.36M145.88M146.68M147.94M147.47M152.65M160.54M163.31M162.79M178.71M187.59M188.51M186.08M190.15M190.52M191.85M
EBITDA -63.75M-69.32M-54.53M-78.64M-102.49M-124.57M-119.94M-127.49M-167.50M-94.02M-149.50M-165.61M-173.68M-80.18M-129.12M-129.23M-126.16M-146.10M-157.69M-177.42M0.34M-175.54M-191.75M-226.03M-104.37M-134.28M-145.20M
Interest Expenses 1.67M1.94M2.11M3.04M4.01M10.75M10.93M10.96M9.74M10.84M11.07M15.13M20.34M20.28M19.82M19.99M20.12M20.59M20.31M20.27M23.47M22.94M23.06M29.82M42.14M37.64M11.74M
Tax Rate 0.83%